ACTOS® BLADDER CANCER LAWSUITS

Lawsuits are currently being filed against the makers of Actos® after studies find an increased risk of bladder cancer.

Many individuals diagnosed with type 2 diabetes have been prescribed Actos® in order to control blood sugar levels. More than 2 million prescriptions for Actos® were filed in 2010 alone. Actos® is the brand name of the drug pioglitazone, manufactured by Takeda Pharmaceuticals. According to recent alerts by the FDA, individuals that have been using Actos® for longer than 12 months are at a 40% increase risk for bladder cancer. The risk is particularly found in men that have been taking Actos®. Kell Lampin, LLC is taking cases for those that have been diagnosed with bladder cancer after taking Actos® and seeking compensation for the injuries suffered due to the failure of the manufacturers to warn patients of the increased risk of bladder cancer. If you have been diagnosed with bladder cancer, and were using the prescription drug Actos®, contact our law firm immediately for a free case evaluation.

What is Actos®?

Actos®, also known as pioglitazone, is a diabetes drug manufactured by Takeda Pharmaceuticals. It is prescribed to adults over the age of 18 that have been diagnosed with type 2 diabetes. It was approved on July 15, 1999 and was meant to be used together with diet and exercise to improve glycemic control of those with type 2 diabetes. It is designed to allow the body to make better use of the insulin produced, which is reduced in most patients with diabetes, by making other cells in the body, such as fat and muscle cells, more sensitive to the insulin.

The FDA has also allowed Actos® to be combined with other drugs including metformin referred to as ActoplusMet or Competact and glimepride referred to as Duetact. A generic form of the drug has not yet been released.

What side effects are associated with Actos® use?

As with many drugs on the market, there are many side effects associated with Actos®. These can include a risk of fractures, hypoglycemia, fluid retentions, and peripheral edema. However, new studies have shown that patients taking Actos® are at a higher risk of bladder cancer. This is especially true for those patients that have been taking the prescription for more than a year.

Bladder cancer can be any type of malignant growth in the urinary bladder. The symptoms of bladder cancer include:

  • Blood in urine
  • Pain during urination
  • Frequent urination (polyuria)
  • Feeling the need to urinate with no results

 

These signs and symptoms however are not specific to bladder cancer, so it is important to consult your physician. Bladder cancer is thought to occur more in those diagnosed with diabetes and is estimated to occur in 20 per 100,000 persons per year in the United States.

FDA Actos® warning regarding bladder cancer

The FDA has recently put out warnings about the use of Actos® and its association with bladder cancer. On, September 17, 2010, an FDA Drug Safety Communication pointed to new studies that showed an increase risk of bladder cancer in those patients that had taken Actos® for longer periods. The FDA took further steps in June of 2011 by adding such risks to the warning and medication guide for Actos® and other pioglitazone-containing medications. The FDA has plans to work closely with Takeda Pharmaceuticals in ongoing studies to determine the extent of the risks.

However, Actos® remains on the market for those suffering from type 2 diabetes in the United States. Unlike Avandia®, which was taken off the market after the FDA found an increase in strokes and heart attacks associated with such drug, Actos® has been allowed to remain on the market in the United States while more studies are conducted. In France the use of pioglitazone has been banned and Germany has stopped allowing any new prescriptions to patients of pioglitazone containing medications.

Actos® bladder cancer lawsuits

Due to the large number of patients prescribed Actos® and the increased incident of bladder cancer in those individuals who have taken Actos® for a longer period of time, Kell Lampin, LLC expects the amount of lawsuits to be generated from the failure of the manufacturers to warn patients to be in the thousands in the next few years.

Our bladder cancer attorneys are now currently looking at cases of individuals harmed while taking Actos®. If you have been diagnosed with bladder cancer and were taking Actos®, please contact the attorneys of Kell Lampin, LLC immediately. Our attorneys are dedicated to seeking compensation for your injuries and helping you navigate the difficult waters of a mass tort pharmaceutical litigation lawsuit. Contact us today, either through our website, or by calling us toll-free at 1-866-804-4357. As always, our attorneys will provide a free initial consultation on your case.

Contact Us for a Free Consultation

    Please select one of the above
  • Use of this website, sending of form, or sending of email to our law firm or a specific attorney does not establish an attorney-client relationship nor begin a lawsuit. Communication through this website is not a secure method of communication and may be copied or intercepted as it goes from sender to recipient through the internet.